ArticleInternational journal of molecular sciences2026
Bioactive Peptide Fractions from Mung Bean Protein Hydrolysate: Antioxidant Activity, Anti-Inflammatory Effects, and Immunomodulatory Responses in RAW 264.7 Macrophages.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Amid growing concerns over climate change and the need for sustainable agriculture, the study investigated the antioxidant, anti-inflammatory, and immunomodulatory activities of MBPH fractions. MBPH was produced via alcalase hydrolysis and fractionated by ultrafiltration into >5, 3-5, 1-3, and <1 kDa fractions. Bioactivity exhibited a clear inverse correlation with molecular weight. The <1 and 1-3 kDa fractions demonstrated their highest antioxidant capabilities through their performance in ORAC and ABTS tests, which produced results of 836.51 ± 11.81 µmol TE/g and 19.36 ± 0.71 µmol TE/g, respectively. Both fractions also demonstrated significant in vitro anti-inflammatory potential, with the <1 kDa fraction showing superior activity by inhibiting LOX activity (76.93 ± 1.53%) and heat-induced albumin denaturation (81.82 ± 2.72%). All fractions were non-cytotoxic, preserving >90% cell viability in RAW 264.7 macrophages at 100 µg/mL. The 1-3 kDa MBPH fraction exhibited distinct context-dependent immunomodulatory activity in RAW 264.7 macrophages. At 3 h, the fraction markedly suppressed
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.